Our breakthrough, proprietary technology platform engineered to enhance drug absorption
End-to-end, in-house control of formulation, development, and manufacturing capabilities
Our proprietary cannabinoid composition for the management of pain and inflammation
Partnering with the world’s leading research institutions and doctors to support FDA-authorized investigator-initiated clinical trials
Learn more about cannabidiol from the medical community and regulators
We are modernizing the way medicines are taken
Experts in drug development and delivery, manufacturing, and commercialization
Recent media coverage regarding Orcosa
Company news and announcements
We are building the future of drug delivery at scale. Investing in talent and capacity to develop and manufacture all RITe™ products in-house at our state-of-the-art cGMP facility in the USA.
Faster iteration drives innovation. Our robust in-house formulation, analytical, development and manufacturing capabilities give us the ability to accelerate pipeline development and gain flexibility from clinical to commercial scale.
End-to-end control over our processes provide enhanced quality oversight, mitigates third-party risk, and protects the specialized knowledge we’ve developed to produce the RITe™ Platform.
We are proud to invest in our community and manufacture in the USA to support our promise to develop life-changing medications for the benefit of patients around the world.